Our Track Record
The Foundation drives the research of prevention, treatments, and cures for people affected by retinal degenerative diseases.
-
1st gene therapy
for any inherited disease to be approved by the FDA
learn more -
$760M dollars raised
since 1971
learn more -
35 VisionWalk events
throughout the United States
learn more -
80+ grants awarded
in 2019 – over 90 investigators, 67 institutions
Learn more
The Foundation in the News
Genentech’s Port Delivery System for Wet AMD Meets Primary Endpoint in Phase 3 Clinical Trial
-
May 27, 2020 Beacon Stories
Lulie Gund: Beloved Philanthropist, Role Model and Confidant
-
May 21, 2020 Eye On the Cure Research News
Nacuity’s Emerging Anti-Oxidative Therapy Moves into Clinical Trial
-
May 18, 2020 Beacon Stories
Living with vision loss can be difficult, but you don't have to do it alone
View local chaptersGet Involved
-
Take important steps toward a cure by participating in a 5k VisionWalk
Join a Walk -
Join people coming together to find a cure from all over the country
Search Our Events -
Make a difference today and support promising research by donating a one-time gift
Donate Now
Welcome to the new Foundation site — supported in partnership with Genentech, A Member of the Roche Group
